Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Pamela W. Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4960-3753; OpenAlex author ID A5070786585. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 2 papers

Papers 3

  1. Incidence of Venous Thromboembolism in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Chemotherapy. First author DOI 10.1245/s10434-025-18691-x↗
  2. ASO Visual Abstract: Incidence of Venous Thromboembolism in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Chemotherapy. First author DOI 10.1245/s10434-025-18865-7↗
  3. Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00464-024-11022-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew H. G. Katz · 3 shared papers, 2024–2026 · strength 0.77
  2. Naruhiko Ikoma · 3 shared papers, 2024–2026 · strength 0.77
  3. Laura R. Prakash · 3 shared papers, 2024–2026 · strength 0.77
  4. Rebecca Anne Snyder · 3 shared papers, 2024–2026 · strength 0.77
  5. Michael P. Kim · 3 shared papers, 2024–2026 · strength 0.77
  6. Ching-Wei David Tzeng · 3 shared papers, 2024–2026 · strength 0.77
  7. Robin D. Wright · 2 shared papers, 2026 · strength 0.56
  8. Jeffrey E. Lee · 2 shared papers, 2026 · strength 0.56

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.